Funded Tech Companies
Verseau Therapeutics
Verseau Therapeutics, operating out of Bedford, received equity investments from 3SBio, Alexandria Venture Investments and HighLight Capital.
Company Overview
Company Name
Verseau Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
47 Wiggins Ave.
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. With our proprietary all-human translational system we identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/22/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christine Bunt
Chief Financial Officer
Robert Crane
Chief Scientific Officer
Tatiana Novobrantseva
Co-Founder
Igor Feldman
Company Investors
- 3SBio
- Alexandria Venture Investments
- HighLight Capital
- Yonghua Capital
- 20/20 HealthCare Partners
- InHarv Partners
- The Mark Foundation for Cancer Research
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs